US trials of Gilead's remdesivir begin against COVID-19 coro...

The first US trial of Gilead’s unapproved antiviral remdesivir has officially begun against the novel coronavirus disease COVID-19.

Gilead launches phase 3 trials of coronavirus antiviral remd...

Gilead has said it has begun two phase 3 trials of its potential COVID-19 coronavirus antiviral remdesivir in adults affected by the disease, expanding ongoing research in the US and China.

Gilead surges after WHO says remdesivir may combat coronavir...

Gilead’s share price has surged after health experts said its antiviral drug remdesivir is showing signs of efficacy against the deadly COVID-19 coronavirus outbreak.

GSK teams up with Clover on coronavirus vaccine

Coronavirus could threaten US drug supplies - report

About 150 prescription drugs, including antibiotics, generics and some branded drugs without alternatives, could be at risk of shortage if the COVID-19 coronavirus outbreak worsens accordin

Could Gilead's Sovaldi be the answer to COVID-19 coronavirus...

A Chinese research foundation has awarded $2.1m to four teams from Columbia University to identify antiviral drugs that work against the COVID-19 coronavirus – including a project investiga